ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för abacavir. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

15 träffar

Bibliografisk träff 2015-05-29

Acyclovir Has Low but Detectable Influence on HLA-B*57:01 Specificity without Inducing Hypersensitivity.

Metushi IG, Wriston A, Banerjee P, Gohlke BO, English AM, Lucas A, Lucas A, Moore C, Sidney J, Buus S, Ostrov DA, Mallal S, Phillips E, Shabanowitz J, Hunt DF, Preissner R, Peters B.

PLoS One · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1371/journal.pone.0124878

Bibliografisk träff 2015-02-12

Abacavir-reactive memory T cells are present in drug naïve individuals.

Lucas A, Lucas M, Strhyn A, Keane NM, McKinnon E, Pavlos R, Moran EM, Meyer-Pannwitt V, Gaudieri S, D'Orsogna L, Kalams S, Ostrov DA, Buus S, Peters B, Mallal S, Phillips E.

PLoS One · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1371/journal.pone.0117160

Bibliografisk träff 2014-08-01

Antiviral drug allergy.

Milpied-Homsi B, Moran EM, Phillips EJ.

Immunol Allergy Clin North Am · research-article; review; journal article · DOI 10.1016/j.iac.2014.04.011

Bibliografisk träff 2014-04-21

Abacavir induced T cell reactivity from drug naïve individuals shares features of allo-immune responses.

Adam J, Wuillemin N, Watkins S, Jamin H, Eriksson KK, Villiger P, Fontana S, Pichler WJ, Yerly D.

PLoS One · research support, non-u.s. gov't; research-article; journal article · DOI 10.1371/journal.pone.0095339

Bibliografisk träff 2008-06-01

Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity.

Chessman D, Kostenko L, Lethborg T, Purcell AW, Williamson NA, Chen Z, Kjer-Nielsen L, Mifsud NA, Tait BD, Holdsworth R, Almeida CA, Nolan D, Macdonald WA, Archbold JK, Kellerher AD, Marriott D, Mallal S, Bharadwaj M, Rossjohn J, McCluskey J.

Immunity · research support, non-u.s. gov't; journal article · DOI 10.1016/j.immuni.2008.04.020

Bibliografisk träff 2007-10-17

Synthesis, anti-HIV activity, and resistance profiles of ribose modified nucleoside phosphonates.

Mackman RL, Boojamra CG, Prasad V, Zhang L, Lin KY, Petrakovsky O, Babusis D, Chen J, Douglas J, Grant D, Hui HC, Kim CU, Markevitch DY, Vela J, Ray A, Cihlar T.

Bioorg Med Chem Lett · journal article · DOI 10.1016/j.bmcl.2007.10.038

Bibliografisk träff 2007-09-01

Hologram QSAR model for the prediction of human oral bioavailability.

Moda TL, Montanari CA, Andricopulo AD.

Bioorg Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bmc.2007.08.060

Bibliografisk träff 2006-12-15

Inhibition of MRP1/ABCC1, MRP2/ABCC2, and MRP3/ABCC3 by nucleoside, nucleotide, and non-nucleoside reverse transcriptase inhibitors.

Weiss J, Theile D, Ketabi-Kiyanvash N, Lindenmaier H, Haefeli WE.

Drug Metab Dispos · journal article · DOI 10.1124/dmd.106.012765

Bibliografisk träff 2006-06-01

Effect of various pyrimidines possessing the 1-[(2-hydroxy-1-(hydroxymethyl)ethoxy)methyl] moiety, able to mimic natural 2'-deoxyribose, on wild-type and mutant hepatitis B virus replication.

Kumar R, Semaine W, Johar M, Tyrrell DL, Agrawal B.

J Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1021/jm060102l

Bibliografisk träff 2006-03-01

Inhibition of hepatitis B virus (HBV) replication by pyrimidines bearing an acyclic moiety: effect on wild-type and mutant HBV.

Semaine W, Johar M, Tyrrell DL, Kumar R, Agrawal B.

J Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1021/jm058271d

Bibliografisk träff 2006-02-03

Abacavir prodrugs: microwave-assisted synthesis and their evaluation of anti-HIV activities.

Sriram D, Yogeeswari P, Myneedu NS, Saraswat V.

Bioorg Med Chem Lett · evaluation study; journal article · DOI 10.1016/j.bmcl.2006.01.050

Bibliografisk träff 2005-05-01

Application of phosphoramidate pronucleotide technology to abacavir leads to a significant enhancement of antiviral potency.

McGuigan C, Harris SA, Daluge SM, Gudmundsson KS, McLean EW, Burnette TC, Marr H, Hazen R, Condreay LD, Johnson L, De Clercq E, Balzarini J.

J Med Chem · journal article · DOI 10.1021/jm0491400

Bibliografisk träff 2003-06-01

The role of 2',3'-unsaturation on the antiviral activity of anti-HIV nucleosides against 3TC-resistant mutant (M184V).

Choo H, Chong Y, Chu CK.

Bioorg Med Chem Lett · research support, u.s. gov't, p.h.s.; journal article · DOI 10.1016/s0960-894x(03)00330-5

Bibliografisk träff 2001-12-01

Understanding drug hypersensitivity: what to look for when prescribing abacavir.

Hetherington S.

AIDS Read · journal article

Bibliografisk träff 2001-10-01

High-performance liquid chromatographic assay for abacavir and its two major metabolites in human urine and cerebrospinal fluid.

Ravitch JR, Moseley CG.

J Chromatogr B Biomed Sci Appl · journal article · DOI 10.1016/s0378-4347(01)00361-9